Abstract
Freezing of Gait (FOG) is one of the most disabling and least understood symptoms in Parkinson’s disease (PD), and is usually observed in the advanced stage of the disease. FOG can be experienced on turning, in narrow spaces, whilst reaching a destination, and in stressful situations. FOG is commonly observed in the “off” state, but it can also be observed in the “on” state. Dual tasking (cognitive load) aggravates FOG. Visual or auditory cues often resolve FOG. Analysis of gait revealed that the rhythm of stepping suddenly jumps into high frequency (4–5 Hz) in FOG (hastening), and that floor reaction forces are disregulated. Stride-to-stride variability is increased in FOG. Hastening phenomenon was reported not only in PD patients but also in patients with striatal lesions. The basal ganglia and its frontal projections may be one of the essential lesion sites for FOG.A recent study using single-photon emission tomography (SPECT) revealed enhanced lateral premotor cortex (PMC) activity during paradoxical gait in PD, suggesting that PMC can compensate for the impaired function of the medial frontal cortex when cued by visual input. Treatment of FOG includes behavioural, medical, and surgical approaches. Tricks of all kinds (including external cues) are effective therapeutic approaches. If FOG occurs predominantly in the “off” state, dopaminergic therapy can be increased. For “on” freezing or if “on” response is otherwise optimised, the dose of the dopaminergic agent may be manipulated, but it could lead to the deterioration of parkinsonism. Deep brain stimulation of the STN often alleviates FOG in the “off” state.
This is a preview of subscription content, access via your institution.
References
Ambani L,Van Woert M (1973) Start hesitation—a side effect of long-term levodopa therapy. N Eng J Med 288:1113–1115
Achiron AI Ziv, Goren M et al. (1993) Primary progressive freezing gait. Mov Disord 8:293–297
Atchison PR, Thompson PD, Frackowiak RSJ, Marsden CD (1993) The syndrome of gait ignition failure: A report of six cases. Mov Disord 8:285–292
Bakker M, Esselink RA, Munneke M, Limousin-Dowsey P, Speelman HD, Bloem BR (2004) Effects of stereotactic neurosurgery on postural instability and gait in Parkinson’s disease. Mov Disord 19:1092–1099
Barbeau A (1976) Six years of high level levodopa therapy in severely akinetic parkinsonian patients. Arch Neurol 33:333–338
Bartels, AL, Balash Y, Gurevich T et al. (2003) Relationships between freezing of gait (FOG) and other features of Parkinson’s disease. FOG is not correlated with bradykinesia. J Clin Neurosci 10:584–588
Bejjani B, Gervais D, Arnulf I et al. (2000) Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg psychiatry 68:595–600
Bloem BR, Hausdorff JM, Visser JE, Giladi N (2004) Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena. Mov Disord 19:871–884
Brichetto B, Pelosin A, Marchese A, Abbruzzese G (2006) Evaluation of physical therapy in parkinsonian patients with freezing of gait: a pilot study. Clin Rehabil 20:31–35
Camicioli R, Oken BS, Sexton G et al. (1998) Verbal fruency task affects gait in Parkinson’s disease with motor freezing. J Geriatr Psychiatry Neurol 11:181–185
Cubo E, Moore CG, Leurgans S, Goetz CG (2003) Wheeled and standard walkers in Parkinson’s disease patients with gait freezing. Parkinsonism Rel Disord 10:9–14
Cubo E, Leurgans S, Goetz CG (2004) Short-term and practice effects of metronome pacing in Parkinson’s disease patients with gait freezing while in the “on” state: randomized single blind evaluation. Parkinsonism Rel Disord 10:507–510
Davis JT, Lyons KE, Pahwa R (2006) Freezing of gait after bilateral subthalamic nucleus stimulation for Parkinson’s disease. Clin Neurol Neurosurg 108:461–464
Dietz MA, Goetz CG, Stebbins GT (1990) Evaluation of a modified inverted walking stick as a treatment for parkinsonian freezing episodes. Mov Disord 5:243–247
Fabre N, Brefel C, Sabatini U et al. (1998) Normal frontal perfusion in patients with frozen gait. Mov Disord 13:677–683
Factor S, Jennings DL, Molho ES, Marek KL (2002) The natural history of the syndrome of primary progressive freezing gait. Arch Neurol 59:1778–1783
Fahn S (1995) The freezing phenomenon in parkinsonism. Adv Neurol 67:53–63
Fernandez HH, Lannon MC, Trieschenann ME, Friedman JH (2004) Botulinum toxin type B for the gait freezing in Parkinson’s disease. Med Sci Monit 10:282–284
Ferrarin M, Brambilla M, Garavello L et al. (2004) Microprocessor-controlled optical stimulating device to improve the gait of patients with Parkinson’s disease. Med Biol Eng Comput 42:328–332
Fukuyama H, Ouchi Y, Matsuzaki S et al. (1997) Brain functional activity during gait in normal subjects: a SPECT study. Neurosci Lett 228:183–186
Giladi N, McMahon D, Przedborski et al. (1992) Motor blocks in Parkinson’s disease. Neurology 42:333–339
Giladi N, Kao R, Fahn S (1997) Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 12:302–305
Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with parkinsonism. Parkinsonism Rel Disord 6:165–170
Giladi N, Shabtai H, Rozenberg E, Shabtai E (2001) Gait festination in Parkinson’s disease. Parkinsonism Rel Disord 7:135–138
Giladi N (2001) Freezing of gait. Clinical overview. Adv Neurol 87:191–197
Giladi N, Treves TA, Simon ES, Shabtai H et al. (2001) Freezing of gait in patients with advanced Parkinson’s disease. J Neural Transm 108:53–61
Giladi N, Guerevich T, Shabtai H, Paleacu D, Simon ES (2001) The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. J Neurol 248:572–576
Giladi N, McDermott MP, Fahn S et al. (2001) Freezing of gait in Parkinson’s disease; prospective assessment in the DATATOP cohort. Neurology 56:1712–1721
Gurevich T, Giladi N (2003) Freezing of gait in multiple system atrophy (MSA). Parkinsonism Rel Disord 9:169–174
Hanakawa T, Katsumi Y, Fukuyama H et al. (1999) Mechanism underlying gait disturbance in Parkinson’s disease: a Single photon emission computed tomography study. Brain 112:1271–1282
Hanakawa T, Fukuyama H, Katsumi Y et al. (1999) Enhanced lateral premotor activity during paradoxical gait in Parkinson’s disease. Ann Neurol 45:329–336
Hausdorff JM, Schaafsma JD, Balash Y, Bartels AL, Gurevich T, Giladi N (2003) Impaired regulation of stride variability in Parkinson’s disease subjects with freezing of gait. Exp Brain Res 149:187–194
Imai H (1980) Syndrome of pure akinesia or freezing phenomenon without rigidity and tremor and with no effect by L-Dopa therapy. Adv Neurol Res (Tokyo) 24:838–848
Imai H, Narabayashi H, Sakata E (1986) “Pure akinesia” and the later added supranuclear ophthalmoplegia. Adv Neurol 45:207–212
Imai H (1993) Festination and freezing. Rinsho Shinkeigaku 33:1307–1309
Jiang Y, Norman KE (2006) Effects of visual and auditory cues on gait initiation in people with Parkinson’s disease. Clin Rehabil 20:36–45
Katayama Y, Kasai M, Oshima H, Fukaya C, Yamamoto T (2000) Effects of anterodorsal pallidal stimulation on gait freezing (kinesia paradoxa) in Parkinson’s disease. Stereotact Funct Neurosurg 74:99–105
Kompoliti K, Goetz CG, Leurgans S, Morrissey M, Siegel IM (2000) “On” freezing in Parkinson’s disease: resistance to visual cue walking devices. Mov Disord 15:309–312
Lamberti P, Armenise S, Castaldo V et al. (1997) Freezing gait in Parkinson’s disease. Eur Neurol 38:297–301
Matsui H, Udaka F, Miyoshi T et al. (2005) Three-demensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson’s disease. Mov Disord 20:1272–1277
Muller J, Seppi K, Stefanova N, Poewe W, Litvan I, Wenning GK (2002) Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov Disord 17:1041–1045
Nagasaki H, Kosaka K, Nakamura R (1981) Disturbance of rhythm formation in patients with hemispheric lesion. Tohoku J Exp Med 135:231–236
Nakamura R, Nagasaki H, Narabayashi H (1976) Arrhythmokinesia in parkinsonism. In: Birkmayer W, Hornykievicz O (eds) Advances in Parkinsonism. Roche, Basel, pp 258–268
Narabayashi H, Kondo T, Hayashi A et al. (1981) L-threo-3,4,dihydroxyphenylserine treatment for akinesia and freezing of parkinsonism Proc Jap Acad 57:351–354
Narabayashi H, Kondo T (1987) Results of a double-blind study of L-threo-DOPS in parkinsonism. In: Fahn S, Marsden CD, Gold stein M (eds) Recent developments in Parkinson’s disease. New York. MacMillan, pp 279–291
Narabayashi H (1993) Three types of akinesia in the progressive course of Parkinson’s disease. Adv Neurol 60:18–24
Nieuwboer A, Feys P, DeWeerdt W, Dom R (1997) Is using a cue to the treatment of freezing in Parkinson’s disease? Physiotherapy Res International 2:125–134
Nieuwboer A, Dom R, De Weerdt W, Desloovere K, Fiuws S, Broens-Kaucsik E (2001) Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson’s disease. Mov disord 16:1066–1075
Nieuwboer A, Dom R, De Weerdt W, Desloovere K, Janssens L, Stijn V (2004) Electromyographic profiles of gait prior to onset of freezing episodes in patients with Parkinson’s disease. Brain 127:1650–1660
Ogawa N, Kuroda H, Yamamoto M et al. (1984) Improvement in freezing phenomenon of Parkinson’s disease after DL-threo-3,4-dihydroxyphenylserine Acta Med Okayama 38:301–304
Parkinson J (1817) An essay on the shaking palsy. London: Sherwood, Neerby and Jones
Plotnik M, Giladi N, Balash Y, Peretz C, Hausdorff JM (2006) Is freezing of gait in Parkinson’s disease related to asymmetric motor functions? Ann Neurol 57:656–663
Schaafsma JD, Balash Y, Gurevich T, Bartels AL, Hausdorff JM, Giladi N (2003) Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson’s disease. Eur J Neurol 10:391–398
Shoulson I, Oakes D, Fahn S et al. (2002) Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson’s disease: a randomized controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial. Ann Neurol 51:604–612
Stern G, Lander C, Lees A (1980) Akinetic freezing and trick movements in Parkinson’s disease. J Neural Transm 16(Suppl):137–141
Stolze H, Klebe S, Poepping M et al. (2001) Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology 57:144–146
Ueno E, Yanagisawa N, Takami M (1993) Gait disorders in parkinsonism. A study with floor reaction forces and EMG. In: Narabayashi H, Nagatsu T, Yanagisawa N et al. (eds) Parkinson’s disease. From basic research to treatment. New York: Raven Press, pp 414–418
Wieler M, Camicioli R, Jones CA, Martin WR (2005) Botulinum toxian injections do not improveve freezing of gait on Parkinson disease. Neurology 65:626–628
Yanagisawa N, Ueno E, Takami M (1991) Frozen gait of Parkinson’s disease and parkinsonism. A study with floor reaction forces and EMG. In: Shimamura M, Grillner S, Edgerton VR (eds) Neurophysiological basis of human locomotion. Tokyo: Japan Scientific Societies Press, pp 291–304
Yokochi F (2006) Effect of deep brain stimulation on FOG. Parkinsonism Rel Disord (in press)
Yokoyama T, Sugiyama K, Nishizawa S, Yokota N, Ohta S, Uemura K (1999) Subthalamic nucleus stimulation for gait disturbance in Parkinson’s disease. Neurosurgery 45:41–47
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Okuma, Y. Freezing of gait in Parkinson’s disease. J Neurol 253 (Suppl 7), vii27–vii32 (2006). https://doi.org/10.1007/s00415-006-7007-2
Issue Date:
DOI: https://doi.org/10.1007/s00415-006-7007-2